POMC and hepatocellular carcinoma: (2) After mid-course treatment of HAIC (i.e., 2 weeks), ACTH score can be evaluated [43, 49], which is likely to increase the number of candidates for sorafenib treatment, and might allow the use of sorafenib earlier in the treatment of HCC non-responders.